HEALTHEQUITY, INC. — Earnings
Most recent reported period: FY2026 (Q4) (filed for period ending 2026-01-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2026-01-31 | $335M | ↑+7.3% | $50M | ↑+88.7% | 21.2% |
| 2025-10-31 | $322M | ↑+7.2% | $52M | ↑+806.4% | 24.4% |
| 2025-07-31 | $326M | ↑+8.6% | $60M | ↑+67.1% | 27.5% |
| 2025-04-30 | $331M | ↑+15.0% | $54M | ↑+87.1% | 25.1% |
| 2025-01-31 | $312M | ↑+18.8% | $26M | ↑+0.0% | 13.5% |
| 2024-10-31 | $300M | ↑+20.5% | $6M | ↓-61.1% | 6.5% |
| 2024-07-31 | $300M | ↑+23.1% | $36M | ↑+238.6% | 19.6% |
| 2024-04-30 | $288M | ↑+17.7% | $29M | ↑+603.8% | 14.5% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2026 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 54 quarters
margin trajectory tells the operating-leverage storyGo deeper
HQY Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyHQY Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics